Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol

H. B. Rubins, S. J. Robins, D. Collins

Research output: Contribution to journalShort surveypeer-review

Fingerprint

Dive into the research topics of 'Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol'. Together they form a unique fingerprint.